Cargando…
Mucopolysaccharidoses and the blood–brain barrier
Mucopolysaccharidoses comprise a set of genetic diseases marked by an enzymatic dysfunction in the degradation of glycosaminoglycans in lysosomes. There are eight clinically distinct types of mucopolysaccharidosis, some with various subtypes, based on which lysosomal enzyme is deficient and symptom...
Autores principales: | Sahin, Onur, Thompson, Hannah P., Goodman, Grant W., Li, Jun, Urayama, Akihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484072/ https://www.ncbi.nlm.nih.gov/pubmed/36117162 http://dx.doi.org/10.1186/s12987-022-00373-5 |
Ejemplares similares
-
Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
por: Sonoda, Hiroyuki, et al.
Publicado: (2022) -
ENT and mucopolysaccharidoses
por: Bianchi, Pier Marco, et al.
Publicado: (2018) -
Diagnosis of Mucopolysaccharidoses
por: Kubaski, Francyne, et al.
Publicado: (2020) -
Glaucoma in mucopolysaccharidoses
por: Kong, Weijing, et al.
Publicado: (2021) -
Anesthesiological risks in mucopolysaccharidoses
por: Moretto, Alessandra, et al.
Publicado: (2018)